Sonic Incytes Medical
About Sonic Incytes Medical
Sonic Incytes Medical Corp. is a health technology company at the forefront of addressing the global epidemic of chronic liver disease, specifically Metabolic dysfunction–associated steatotic liver disease (MASLD) and Metabolic dysfunction–associated steatohepatitis (MASH). Their flagship product, Velacur™, is an innovative, portable, and handheld point-of-care ultrasound elastography device engineered to deliver accessible, affordable, and accurate non-invasive liver assessments directly at the point of care.
Velacur™ leverages proprietary technology akin to MRI elastography, utilizing steady-state waves to precisely quantify liver tissue stiffness and attenuation. A key feature of the device is its AI-guided output measurement for liver fat, known as Velacur Determined-Fat Fraction (VDFF). This VDFF algorithm received FDA clearance in 2024 and has demonstrated a strong correlation (r = 0.85) with MRI-PDFF, which is considered the gold standard for liver fat measurement. The system facilitates 3D tissue sampling and provides immediate, highly accurate results, empowering physicians to confidently diagnose, monitor, and manage chronic liver conditions within approximately five minutes during a patient’s office visit.
The company’s overarching mission is to establish liver health as a new vital sign by offering a cost-effective diagnostic solution that can be seamlessly integrated into diverse clinical settings with minimal upfront investment. Velacur™ aims to significantly enhance the early detection and ongoing monitoring of MASLD and MASH, conditions that are frequently underdiagnosed and can lead to severe complications, including cirrhosis, liver failure, and cancer, if left unaddressed. Furthermore, the device’s AI-based scanning guide is designed to improve ease of use, making accurate scans more achievable for non-expert users and potentially paving the way for broader adoption in primary care settings.
Focus Areas
Business Intelligence
| Key Investors | Nimbus Synergies, Nicola Wealth, Mint Venture Partners, Consortium Medteq, Wavemaker Three-Sixty Health, Gaingels, INP Capital, INOVAIT Focus Fund, Genome BC, Small World Group, Think Top Investments, Sunhope Venture Capital, World Changing Ventures, TMFOX, UBC Seed Fund, E-Fund, Mana Ventures, MEDTEQ Invest, Quimby Investments, Pacific Hi-Tech |
| Partnerships | Madrigal Pharmaceuticals (clinical trial), Northwell Health (Velacur trial) |
| Technology | Point-of-care ultrasound elastography, 3D S-WAVE technology, AI-based scanning guide (Organ Guide, Wave Quality Detector), Velacur Determined-Fat Fraction (VDFF) algorithm, external activation source for shear wave generation, cloud-native (implied by AI guidance and data transfer) |
| FDA Clearances | 3 cleared products (estimated) |
What Physicians Need to Know
Sonic Incytes Medical's Velacur ONE offers physicians a powerful, accessible tool for managing chronic liver diseases. Its AI-guided, non-invasive approach simplifies liver assessment, providing quantitative data on liver stiffness, attenuation, and fat fraction (VDFF) that correlates strongly with MRI-PDFF, the gold standard for liver fat measurement. This enables confident diagnosis, monitoring of disease progression, and assessment of treatment response, particularly crucial with the emergence of new MASH therapeutics. The device's portability, ease of use (even for non-sonographers), and potential for higher reimbursement (3-4x higher than non-imaging elastography) make it an economically attractive and clinically valuable addition to point-of-care settings. It aligns with current clinical guidelines for screening high-risk patients and can significantly improve patient management by providing immediate, actionable insights.
Velacur ONE is designed for seamless integration into existing clinical workflows at the point of care. Its pre-installed AI-guided software and comprehensive training program enable medical professionals, including medical assistants and nurse practitioners, to operate the device efficiently and effectively. The device's ability to provide immediate, quantitative results supports rapid clinical decision-making and patient counseling without the need for external imaging specialists or complex data interpretation. Its B-mode imaging capabilities further enhance its utility and potential for improved reimbursement.
What the Web Says
Sonic Incytes Medical is a company focused on developing AI-guided, non-invasive ultrasound technology for assessing and monitoring chronic liver disease. Their flagship product, Velacur, and its next-generation version, Velacur ONE, have received FDA clearance and are designed to provide real-time, accurate measurements of liver stiffness, attenuation, and fat content at the point of care. While the technology and its mission are praised, employer reviews indicate significant issues with leadership and workplace culture.
Overall: MixedStrengths
- Breakthrough, handheld ultrasound solution for chronic liver disease assessment.
- Velacur ONE offers AI-guided, real-time quantification of liver stiffness, attenuation, and VDFF (Velacur Determined-Fat Fraction).
- High accuracy (95%) in detecting hepatic steatosis.
- Comparable to MRI for liver fat quantification, considered the gold standard.
- Enhanced portability and redesigned interface in Velacur ONE.
- Affordable and accessible point-of-care liver imaging.
Limitations
- Toxic/abusive leadership.
- Negative work environment and culture.
- Employees feel that nobody can accomplish anything due to senior leadership.
Based on reviews from: Indeed.com, AuntMinnie, Patsnap Synapse, Sonic Incytes Website
Last updated: 2026-07-20
Videos
News, demos, and interviews about Sonic Incytes Medical.
Videos load interactively. If none appear, search YouTube for Sonic Incytes Medical →
Press & Coverage
Frequently Asked Questions
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]